Myeloperoxidase gene-463G > A polymorphism and premature coronary artery disease
2009

Myeloperoxidase Gene Polymorphism and Heart Disease

Sample size: 459 publication 10 minutes Evidence: moderate

Author Information

Author(s): Zhong Chen, Quanzhong Yin, Genshan Ma, Hua Zhang, Ruolong Zheng, Jiahong Wang, Chunheng Gao

Primary Institution: The Affiliated ZhongDa Hospital of Southeast University

Hypothesis

Is there an association between myeloperoxidase gene -463G > A polymorphism and premature coronary artery disease in Chinese populations?

Conclusion

The -463G > A polymorphism of the myeloperoxidase gene is associated with a reduced risk of premature coronary artery disease in Chinese individuals.

Supporting Evidence

  • The AA genotype was found to be significantly less frequent in patients with premature CAD compared to controls.
  • Carriers of the AA genotype had an 83% reduced risk of premature CAD compared to those with the G/G genotype.
  • The study included a total of 459 patients, with 229 diagnosed with premature CAD.

Takeaway

This study found that a specific gene change might help protect some people from getting heart disease at a young age.

Methodology

The study involved genotyping patients and controls using ligase detection reaction and polymerase chain reaction sequencing.

Potential Biases

Potential bias due to the study being limited to a single center and the relatively infrequent AA genotype.

Limitations

The study was conducted at a single hospital, which may not represent the broader population.

Participant Demographics

229 patients with premature CAD (men aged 36-54 years and women aged 39-64 years) and 230 age- and sex-matched controls.

Statistical Information

P-Value

0.002

Confidence Interval

0.057-0.526

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1590/S1415-47572009005000035

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication